Detection and Characterization of a New Metabolite of 17α-Methyltestosterone
- 24 August 2009
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 37 (11), 2153-2162
- https://doi.org/10.1124/dmd.109.028373
Abstract
The misuse of the anabolic steroid methyltestosterone is currently routinely monitored in doping control laboratories by gas chromatography-mass spectrometry (GC-MS) of two of its metabolites: 17α-methyl-5β-androstane-3α,17β-diol and 17α-methyl-5α-androstane-3α,17β-diol. Because of the absence of any easy ionizable moiety, these metabolites are poorly detectable using liquid chromatography-tandem mass spectrometry (LC-MS/MS) with electrospray ionization (ESI). In this study, the metabolism of methyltestosterone has been reinvestigated by the use of a precursor ion scan method in LC-ESI-MS/MS. Two metabolites have been detected using this method. Both compounds have been confirmed in postadministration urine samples of an urokinase plasminogen activator-severe combined immunodeficiency (uPA-SCID) mouse with humanized liver and were characterized by LC-MS/MS and GC-MS using both quadrupole and time of flight analyzers. From the detailed study of the fragmentation, these metabolites were proposed to be epimethyltestosterone and a dehydrogenated compound. Epimethyltestosterone has previously been described as a minor metabolite, whereas the occurrence of the oxidized metabolite has not been reported. Comparison with the synthesized reference revealed that the structure of the dehydrogenated metabolite is 6-ene-epimethyltestosterone. A selected reaction monitoring method including three transitions for each metabolite has been developed and applied to samples from an excretion study and to samples declared positive after GC-MS analysis. 6-Ene-epimethyltestosterone was found in all samples, showing its applicability in the detection of methyltestosterone misuse.Keywords
This publication has 29 references indexed in Scilit:
- uPA+/+-SCID Mouse with Humanized Liver as a Model for In Vivo Metabolism of Exogenous Steroids: Methandienone as a Case StudyClinical Chemistry, 2009
- Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivoHepatology, 2008
- Preventive doping control analysis: liquid and gas chromatography time‐of‐flight mass spectrometry for detection of designer steroidsRapid Communications in Mass Spectrometry, 2007
- A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometryAnalytica Chimica Acta, 2007
- A stereochemical examination of the equine metabolism of 17α-methyltestosteroneAnalytica Chimica Acta, 2007
- A fast liquid chromatographic/mass spectrometric screening method for the simultaneous detection of synthetic glucocorticoids, some stimulants, anti‐oestrogen drugs and synthetic anabolic steroidsRapid Communications in Mass Spectrometry, 2006
- Collision-induced dissociation pathways of anabolic steroids by electrospray ionization tandem mass spectrometryJournal of the American Society for Mass Spectrometry, 2006
- Metabolism of methyltestosterone, norethandrolone and methylboldenone in a heiferAnalytica Chimica Acta, 2005
- In vivo biotransformation of 17α‐methyltestosterone in the horse revisited: identification of 17‐hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometryRapid Communications in Mass Spectrometry, 2003
- Testing for natural and synthetic anabolic agents in human urineJournal of Chromatography B: Biomedical Sciences and Applications, 1996